LIVER CANCER
Clinical trials for LIVER CANCER explained in plain language.
Never miss a new study
Get alerted when new LIVER CANCER trials appear
Sign up with your email to follow new studies for LIVER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for liver cancer: experimental combo aims to extend life
Disease control Not yet recruitingThis study tests whether adding the experimental drug zanzalintinib to the approved drug durvalumab can help people with advanced liver cancer live longer. It is for patients whose cancer was stable or improved after initial treatment with tremelimumab and durvalumab. About 16 ad…
Matched conditions: LIVER CANCER
Phase: PHASE2 • Sponsor: Amit Mahipal • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New combo therapy aims to control advanced liver cancer
Disease control Not yet recruitingThis study tests a new treatment plan for people with intermediate or advanced liver cancer. It combines chemotherapy delivered directly to the liver, a procedure to block the tumor's blood supply, and two drugs (apatinib and camrelizumab) that help the immune system fight cancer…
Matched conditions: LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New cell therapy aims to shrink Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a new cell therapy called SL-28 for people with advanced solid tumors that have not responded to standard treatments. The therapy uses donor immune cells to attack the cancer. The goal is to see if it is safe and can shrink tumors in up to 60 participants with va…
Matched conditions: LIVER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Gene test may unlock better cancer treatments for Hard-to-Treat tumors
Knowledge-focused Not yet recruitingThis study looks at whether doing broad gene testing early, instead of later, can help find more effective treatments for people with advanced liver, breast, or pancreatic cancers. About 360 adults with poor-prognosis cancers will be randomly assigned to early or standard gene te…
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 17, 2026 03:11 UTC
-
3D models could make liver surgery safer
Knowledge-focused Not yet recruitingThis study checks if custom 3D liver models help surgeons better predict how much liver to remove during major surgery. About 25 adults having liver resection will get a 3D model before surgery. After surgery, the removed piece is scanned to see if the model's prediction matches …
Matched conditions: LIVER CANCER
Phase: NA • Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC